GLOBE Model Finalised, with Narrowed Scope and Fewer Savings

Medicare drug pricing model to impact only four firms (LLY)

HHS finalized the GLOBE drug pricing model for Medicare Part B, cutting projected savings and narrowing scope as MFN waivers may leave just 4 drugmakers. Read more here.

Medicare de-fangs new drug pricing model

Click in for more news from The Hill {beacon} Healthcare Healthcare   The Big Story  Medicare de-fangs new drug pricing model The Trump administration rolled out the final version of a new Medicare payment model aimed at lowering the prices of drugs administered in doctors’ offices to match those paid in countries overseas.  © Nam…

Trump Medicare drug pricing model may apply to only four companies after exemptions - Regional Media News

NEW YORK, Oct 1 (Reuters) - A Trump administration rule to cut hospital drug prices for Medicare patients may apply to as few as four drugmakers after exempting companies that signed separate "most favored nation" pricing agreements with the administration, according to the finalized rule. [...]

Medicare Finalizes GLOBE Model Tying Some Part B Drug Rebates to Foreign Prices, with Far Smaller Savings

CMS finalized GLOBE, tying some Medicare Part B drug rebates to prices abroad. Here's who is included, when costs drop, and what changed.

Trump Medicare drug pricing model may apply to only four companies after exemptions

NEW YORK, Oct 1 (Reuters) - A Trump administration rule to cut hospital drug prices for Medicare patients may apply to as ​few as four drugmakers after exempting ‌companies that signed separate "most favored nation" pricing agreements with the administ...

GLOBE model finalised, with narrowed scope and fewer savings

CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.